• 대한수의학회지
• /
• 제44권4호
• /
• pp.561-569
• /
• 2004

To detect viral agents and isolate porcine circovirus 2 (PCV2), 60 samples of lung and lymph node were collected from 5 to 12 week-old pigs that had showed clinical signs of postweaning multisystemic wasting syndrome (PMWS). Polymerase chain reactions (PCRs) were conducted to identify the viral pathogens including PCV1, PCV2, porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) that have been considered to be the causal agents of PMWS. Among 60 samples, PCV 2 was detected from 57 samples but no PCV 1 was detected. PRRSV and/or PPV were also detected from 27 (47.4%) samples and 1 (1.8%) sample of these 57 PCV 2-positive samples, respectively. Tissue homogenates were inoculated onto PCV-free PK-15 cell monolayers. Seven isolates were confirmed as PCV 2 by multiplex PCR, indirect immunofluorescence assay, and transmissible electron microscopy. These date suggest that PRRSV is a major cofactors causing PMWS in pigs that were infected with PCV2 in Korea.

• 한국식물병리학회:학술대회논문집
• /
• 한국식물병리학회 2004년도 The 2004 KSPP Annual Meeting & International Symposium
• /
• pp.68-69
• /
• 2004

See Full Text

• 한국어병학회지
• /
• 제23권3호
• /
• pp.369-377
• /
• 2010

2005년부터 2007년 사이 매분기별로 포항, 울산, 기장, 거제, 완도 지역에서 채집한 양식넙치를 대상으로 기생충, 세균 및 바이러스에 대한 병원체 모니터링 결과를 분석하였다. 총 2,238마리 중 1,528마리(68.3%)에서 병원체가 검출되었다. 연도별 검출률을 비교한 결과, 2005년도에는 60.6%, 2006년도에는 66.7%, 2007년도에는 72.3%의 병원체 검출률을 나타내어 해마다 증가하는 것으로 나타났다. 조사시기별 총 병원체 검출률은 2월에 63.5%, 5월에 67.3%, 8월에 75.1%, 11월에 64.2%로 나타났다. 기생충, 세균 및 바이러스의 검출률은 각각 36.7%, 32.8%, 31.4%로 나타났다. 병원체의 단독감염률 및 혼합감염률은 각각 33.6%와 34.6%로 나타났다. 질병별 분포 조사에서 가장 높은 검출률을 나타낸 병원체는 Trichodina sp. (28.2%), viral nervous necrosis virus (24.3%), Vibrio spp. (11.6%), viral hemorrhagic septicaemia virus (10.5%) 순으로 나타났다.

• Journal of Microbiology and Biotechnology
• /
• 제32권12호
• /
• pp.1515-1526
• /
• 2022

Eukaryotic chromatin is highly organized in the 3D nuclear space and dynamically regulated in response to environmental stimuli. This genomic organization is arranged in a hierarchical fashion to support various cellular functions, including transcriptional regulation of gene expression. Like other host cellular mechanisms, viral pathogens utilize and modulate host chromatin architecture and its regulatory machinery to control features of their life cycle, such as lytic versus latent status. Combined with previous research focusing on individual loci, recent global genomic studies employing conformational assays coupled with high-throughput sequencing technology have informed models for host and, in some cases, viral 3D chromosomal structure re-organization during infection and the contribution of these alterations to virus-mediated diseases. Here, we review recent discoveries and progress in host and viral chromatin structural dynamics during infection, focusing on a subset of DNA (human herpesviruses and HPV) as well as RNA (HIV, influenza virus and SARS-CoV-2) viruses. An understanding of how host and viral genomic structure affect gene expression in both contexts and ultimately viral pathogenesis can facilitate the development of novel therapeutic strategies.

• Clinical and Experimental Pediatrics
• /
• 제61권6호
• /
• pp.180-186
• /
• 2018

Purpose: Despite the availability of molecular methods, identification of the causative virus in children with acute respiratory infections (ARIs) has proven difficult as the same viruses are often detected in asymptomatic children. Methods: Multiplex reverse transcription polymerase chain reaction assays were performed to detect 15 common respiratory viruses in children under 15 years of age who were hospitalized with ARI between January 2013 and December 2015. Viral epidemiology and clinical profiles of single virus infections were evaluated. Results: Of 3,505 patients, viruses were identified in 2,424 (69.1%), with the assay revealing a single virus in 1,747 cases (49.8%). While major pathogens in single virus-positive cases differed according to age, human rhinovirus (hRV) was common in patients of all ages. Respiratory syncytial virus (RSV), influenza virus (IF), and human metapneumovirus (hMPV) were found to be seasonal pathogens, appearing from fall through winter and spring, whereas hRV and adenovirus (AdV) were detected in every season. Patients with ARIs caused by RSV and hRV were frequently afebrile and more commonly had wheezing compared with patients with other viral ARIs. Neutrophil-dominant inflammation was observed in ARIs caused by IF, AdV, and hRV, whereas lymphocyte-dominant inflammation was observed with RSV A, parainfluenza virus, and hMPV. Monocytosis was common with RSV and AdV, whereas eosinophilia was observed with hRV. Conclusion: In combination with viral identification, recognition of virus-specific clinical and laboratory patterns will expand our understanding of the epidemiology of viral ARIs and help us to establish more efficient therapeutic and preventive strategies.

• Tuberculosis and Respiratory Diseases
• /
• 제81권4호
• /
• pp.349-349
• /
• 2018

• Journal of Microbiology and Biotechnology
• /
• 제23권7호
• /
• pp.1041-1045
• /
• 2013

The xTAG$^{(R)}$ Gastrointestinal Pathogen Panel (GPP) is a multiplexed molecular test for 15 gastrointestinal pathogens. The sensitivity and specificity of this test were assessed in 901 stool specimens collected from pediatric and adult patients at four clinical sites. A combination of conventional and molecular methods was used as comparator. Sensitivity could be determined for 12 of 15 pathogens and was 94.3% overall. The specificity across all 15 targets was 98.5%. Testing for the pathogen identified was not requested by the physician in 65% of specimens. The simultaneous detection of these 15 pathogens can provide physicians with a more comprehensive assessment of the etiology of diarrheal disease.

• 식물병연구
• /
• 제25권2호
• /
• pp.49-61
• /
• 2019

식물 바이러스는 작물 생산량 손실을 일으키는 주요 병원체 중 하나로, 돌연변이 발생이 빈번하고 치료 약제가 개발되어 있지 않아 방제가 매우 어렵다. 이러한 바이러스병을 방제하기 위한 가장 효과적인 방법은 저항성 품종을 재배하는 것이며, 바이러스 저항성 품종을 개발하기 위해서는 바이러스와 기주 식물 간의 다양한 유전자적 상호작용에 대한 정확한 이해가 필요하다. 열성 저항성은 병원체가 살아가는데 필요한 식물 유전자가 결핍되었을 때 획득되는데, 저항성 유전자(R gene)에 의해 유도되는 우성 저항성에 비해 넓은 범위의 저항성을 발현하고 돌연변이 출현에 쉽게 저항성이 깨지지 않는 특성을 보인다. 현재까지 알려진 바이러스병에 대한 열성 저항성 유전자는 대부분 순행유전학(forward genetics)를 통해 밝혀졌으나, 최근 CRISPR/Cas9 등을 이용한 유전자 교정 기술의 급속한 발전에 힘입어 역유전학(reverse genetics)을 통한 열성 저항성 작물개발의 가능성이 열리고 있다. 이러한 역유전학적 접근을 통한 열성 저항성 작물 개발은 먼저 바이러스 단백질과 상호작용하는 기주 인자를 밝히고 이들간의 상호작용을 억제하도록 하는 기주 인자에 대한 유전자 교정을 통해 이루어 질 수 있다. 본 논문에서는 열성 저항성에 대한 소개와 새로운 열성 저항성 후보 유전 소재 발굴을 위한 기주 인자 연구의 중요성 및 방법을 소개하고, 열성 저항성 작물 개발에 적용할 수 있는 유전자 교정기술의 최신 동향에 관해 정리하였다.

• Pediatric Infection and Vaccine
• /
• 제27권2호
• /
• pp.90-101
• /
• 2020

목적: 급성 위장염의 대부분의 경우 원인 병원체가 확인되지 않는다. 최근 들어 발달한 multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) 검사는 장염 병원체 검출에 도움을 줄 수 있다. 이 연구는 multiplex RT-PCR을 이용해, 소아 장염환자에서 병원체의 역학을 조사하고자 하였다. 방법: 2015년 5월부터 2018년 6월까지 대한민국 서울의 2차병원에서 급성 위장염으로 진단받은 소아 환자의 대변에서 병원체를 확인하기 위해 multiplex RT-PCR 검사를 시행하였다. 결과: 바이러스 병원체에 대한 1,366개의 대변 검체 중, 483개(35.3%)에서 1개 이상의 병원체가 분리되었다. A군 로타바이러스는 106건(7.8%)에서 확인되었으며, 양성률은 3.0% (8/263)에서 16.7% (48/288)까지 매년 증가했다(P<0.001). 노로바이러스 GII는 가장 흔한 바이러스성 병원체였고(263/1366, 19.3%), 3년간 양성률은 증가하지 않았다. 세균성 병원체에 대한 304개의 대변 검체 중 캄필로박터(32/304, 10.5%)는 가장 흔한 세균성 병원체였으며, 그 다음으로 Clostridium difficile (toxin B) (22/304, 7.2%), 살모넬라균(17/304, 5.6%)이었다. 이 균들의 양성률은 연구기간 동안 증가하지 않았다. 결론: 로타바이러스 백신 도입 이후 노로바이러스 GII가 소아 장염에서 주요한 병원체였지만, 연구기간 동안 로타바이러스 감염 환자가 증가했고, 특히 2018년에는 급증했다. 따라서 새로운 로타바이러스 균주의 등장 가능성을 포함한 추가 연구가 필요하다. 캄필로박터는 소아 세균성 장염의 주요 원인이며, 적절한 치료를 위해 이 균의 임상적 특성을 고려하고 지속적 감시가 필요하겠다.

• Biomolecules & Therapeutics
• /
• 제26권3호
• /
• pp.242-254
• /
• 2018

Defensins are antimicrobial peptides that participate in the innate immunity of hosts. Humans constitutively and/or inducibly express ${\alpha}$- and ${\beta}$-defensins, which are known for their antiviral and antibacterial activities. This review describes the application of human defensins. We discuss the extant experimental results, limited though they are, to consider the potential applicability of human defensins as antiviral agents. Given their antiviral effects, we propose that basic research be conducted on human defensins that focuses on RNA viruses, such as human immunodeficiency virus (HIV), influenza A virus (IAV), respiratory syncytial virus (RSV), and dengue virus (DENV), which are considered serious human pathogens but have posed huge challenges for vaccine development for different reasons. Concerning the prophylactic and therapeutic applications of defensins, we then discuss the applicability of human defensins as antivirals that has been demonstrated in reports using animal models. Finally, we discuss the potential adjuvant-like activity of human defensins and propose an exploration of the 'defensin vaccine' concept to prime the body with a controlled supply of human defensins. In sum, we suggest a conceptual framework to achieve the practical application of human defensins to combat viral infections.